Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US

INTRODUCTION: Alpha-1 antitrypsin deficiency (AATD) is often not identified in patients with chronic obstructive pulmonary disease (COPD) until advanced stages of disease, despite the availability of genetic testing. While clinical practice guidelines provide recommendations on patients who should b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhaus, Robert, Strange, Charlie, Stone, Glenda, Runken, M Chris, Blanchette, Christopher M, Howden, Reuben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547287/
https://www.ncbi.nlm.nih.gov/pubmed/33116454
http://dx.doi.org/10.2147/COPD.S263297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547287/
https://www.ncbi.nlm.nih.gov/pubmed/33116454
http://dx.doi.org/10.2147/COPD.S263297

Ejemplares similares